The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Apr. 14, 2015
Filed:
Mar. 14, 2013
Applicant:
Ardelyx, Inc., Fremont, CA (US);
Inventors:
Noah Bell, Fremont, CA (US);
Christopher Carreras, Fremont, CA (US);
Dominique Charmot, Fremont, CA (US);
Jeffrey W Jacobs, Fremont, CA (US);
Michael Robert Leadbetter, Fremont, CA (US);
Marc Navre, Fremont, CA (US);
Assignee:
Ardelyx, Inc., Fremont, CA (US);
Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 31/18 (2006.01); C07F 9/60 (2006.01); A61K 31/472 (2006.01); A61K 31/4725 (2006.01); A61K 31/517 (2006.01); A61K 31/662 (2006.01); A61K 31/675 (2006.01); A61K 45/06 (2006.01); C07C 311/29 (2006.01); C07D 217/04 (2006.01); C07D 217/14 (2006.01); C07D 401/12 (2006.01); C07F 9/38 (2006.01); C07F 9/576 (2006.01); C07F 9/6558 (2006.01); C07D 217/16 (2006.01); C07D 215/14 (2006.01);
U.S. Cl.
CPC ...
C07F 9/60 (2013.01); A61K 31/18 (2013.01); A61K 31/472 (2013.01); A61K 31/4725 (2013.01); A61K 31/517 (2013.01); A61K 31/662 (2013.01); A61K 31/675 (2013.01); A61K 45/06 (2013.01); C07C 311/29 (2013.01); C07D 217/04 (2013.01); C07D 217/14 (2013.01); C07D 401/12 (2013.01); C07F 9/3808 (2013.01); C07F 9/3834 (2013.01); C07F 9/3882 (2013.01); C07F 9/5765 (2013.01); C07F 9/65583 (2013.01); C07D 217/16 (2013.01); C07D 215/14 (2013.01);
Abstract
The present disclosure is directed to compounds and methods for treating irritable bowel syndrome, chronic kidney disease and end stage renal disease by administering to a subject in need thereof a compound or a pharmaceutically acceptable salt thereof, wherein the compound has the structure
Bell, Noah. (2015). Compounds and methods for inhibiting nhe-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders (U.S. Patent No. 9006281). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/9006281
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile